0001209191-17-024676.txt : 20170404
0001209191-17-024676.hdr.sgml : 20170404
20170404160723
ACCESSION NUMBER: 0001209191-17-024676
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170403
FILED AS OF DATE: 20170404
DATE AS OF CHANGE: 20170404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-731-8389
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hatfield Jeffrey S.
CENTRAL INDEX KEY: 0001609879
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 17738164
MAIL ADDRESS:
STREET 1: 11080 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-04-03
0
0001339970
aTYR PHARMA INC
LIFE
0001609879
Hatfield Jeffrey S.
C/O ATYR PHARMA, INC.
3545 JOHN HOPKINS COURT, SUITE 250
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (right to buy)
3.50
2017-04-03
4
A
0
32000
0.00
A
2027-04-03
Common Stock
32000
32000
D
The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning May 3, 2017, such that this option will be fully exercisable on April 3, 2020, subject to the recipient's continued service on the Issuer's Board of Directors.
Nancy D. Krueger, Attorney-In-Fact
2017-04-04